The most common prodromal symptom of Parkinson disease among community-dwelling older adults was cognitive deficit, followed by subthreshold parkinsonism, urinary dysfunction, and olfactory ...

Leqembi Iqlik, a subcutaneous formation of lecanemab, is now available as a maintenance dosing regimen for the treatment of early Alzheimer disease.

Researchers found a dose-dependent positive association between ambient TCE concentrations and risk for Parkinson disease.

The prevalence rates of all noncommunicable conditions were higher in people with chronic back pain vs those without chronic back pain.

Researchers examined whether preterm delivery, known to affect future cardiovascular health, was linked to stroke incidence in Black women. This group was specifically investigated due to their higher ...

This case of a 80-year-old woman with chest pain is used to demonstrate the signs and symptoms of sundowning, along with its management.

The FDA has granted Fast Track designation to ALTO-101 for the treatment of cognitive impairment associated with schizophrenia.

For patients with vestibular schwannoma, those with anxiety have more severe dizziness, according to a recent study.

Melatonin reduces sleep onset latency and improves sleep efficiency and duration in pediatric patients with neurological and psychiatric conditions.

The VasCog-2-WSO criteria revise the original VasCog criteria for diagnosing VCID, offering additional guidance on neuroimaging and fluid biomarkers.

Children and adolescents are twice as likely to experience long COVID after being infected for the second time.

The FDA has granted Fast Track designation to Bristol Myers Squibb’s anti-MTBR-tau antibody (BMS-986446) for the treatment of early Alzheimer disease.